Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04412824 · ClinicalTrials.gov registry record · Early Phase 1
Multimodal Neuroimaging of Alcohol Cues, Cortisol Response, and Compulsive Motivation
A Early Phase 1 study, sponsored by Auburn University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 87
- Enrollment target
NCT04412824 is a Early Phase 1 study that has completed, run by Auburn University. The registered enrollment target is 87 participants.
The verdict
NCT04412824, a Early Phase 1 study, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 87 participants
- Enrollment target
Study Summary
This study proposes to examine both the peripheral and central nervous system responses when light social drinkers and binge/heavy social drinkers are exposed to visual ethanol cues, followed by oral ethanol. The findings will provide a greater understanding of the brain mechanisms (cerebral blood flow and functional connectivity) underlying the association between stress, cortisol release, alcohol craving, and alcohol stimulant and sedative effects. This knowledge could be significant in developing new therapies for the treatment of alcoholism.
Interventions
- DRUG Intravenous blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2020-05-22 |
| Est. Completion | 2021-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04412824
The ClinicalTrials.gov registry entry for NCT04412824 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous blood draw is the first listed.
NCT04412824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04412824 about?
NCT04412824 is a clinical study titled "Multimodal Neuroimaging of Alcohol Cues, Cortisol Response, and Compulsive Motivation". This study proposes to examine both the peripheral and central nervous system responses when light social drinkers and binge/heavy social drinkers are exposed to visual ethanol cues, followed by oral ethanol. The findings will provide a greater understanding of the brain mechanisms (cerebral blood f...
What is the current status of trial NCT04412824?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 87 participants. The study started on 2020-05-22. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04412824?
The interventions under investigation include: Intravenous blood draw (DRUG).
Who is sponsoring clinical trial NCT04412824?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.